Newswise — (Canton, Michigan & Mahwah, New Jersey) Today, Mindray and MedTest jointly announced a US exclusive partnership that will greatly expand collaboration between the two organizations. Covering the chemistry and drugs of abuse (DoA) market segments, the agreement spans the BS-200 Clinical Analyzer, the world’s leading bench-top chemistry analyzer, Pointe Scientific’s reagents exclusively manufactured and FDA cleared for the BS-200 analyzer, and MedTest DX’s sales, customer service and support.
The partnership enables US laboratory customers to purchase the analyzer, reagents, and service from one company, MedTest. MedTest will be the exclusive US distributor of the BS-200 analyzer and it’s consumables for the chemistry and moderately complex DoA markets. MedTest will also market the BS-200 analyzer for the highly complex DoA market on a non-exclusive basis. MedTest is committed to providing existing and new customers with enhanced customer support and differentiated products.
Hanjoon Ryu, CEO of MedTest, stated: “US physician office laboratories and small hospital and commercial labs deserve a more integrated service provider who offers innovative instruments and quality reagents. We are delighted to announce this strategic partnership and to ensure that the partnership brings substantial improvement in serving our customers.”
Finn Li, PhD, Sales Manager of Mindray IVD, stated: “We are excited to forge this US exclusive partnership with MedTest. As Mindray has grown rapidly in global markets, this partnership will make it possible for Mindray to further enhance its presence in the US in-vitro diagnostic market and further introduce a series of new and innovative products for the clinical laboratory.”
About MedTest: MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing. In June, MedTest acquired Pointe Scientific, a company that has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981.
About Mindray: Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains the global headquarters in Shenzhen, China, the U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From the main manufacturing and engineering base in China, Mindray supplies through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems.
For additional information, please contact: